Funding-round

Fore Biotherapeutics - Series D-2

CompanyFore Biotherapeutics
Amount$38,000,000
CurrencyUSD
Announcement date2025-05-23
Round typeSeries D-2
Primary source urlhttps://www.finsmes.com/2025/05/fore-biotherapeutics-raises-38m-in-series-d-2-financing.html

Participating investors

CompanyLead
R One
Medicxi
OrbiMed
HBM Healthcare Investments
Wellington Management
Novartis Venture Fund
Cormorant Asset Management
3B Future Health Fund